After springing to global recognition for its rapid development of a novel and highly effective coronavirus vaccine with global partner Pfizer Inc., BioNTech SE is now planning to expand its global footprint through a new Asia Pacific regional headquarters in Singapore.
The Southeast Asian city state will also be home to a planned fully integrated manufacturing facility for mRNA vaccines and...